Last updated at 11 Dec 2025 10:33 PM
Director
DIN: 10531988
Hebbale Venkatesh Shubha is currently associated with 3 companies in various capacities such as Designated Partner, Director and Individual Subscriber. They serve as a Director at NEW PRIYADHARSHINI HOSPITAL LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10531988.Hebbale Venkatesh Shubha is currently involved in 3 different roles. Their most recent position is with AUMKARA ONEHEALTH PRIVATE LIMITED as a Individual Subscriber. The first company Hebbale Venkatesh Shubha was appointed to as a director was NEW PRIYADHARSHINI HOSPITAL LLP. Hebbale Venkatesh Shubha is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Hebbale Venkatesh Shubha is currently associated with 3 companies in various capacities such as Designated Partner, Director and Individual Subscriber. They serve as a Director at NEW PRIYADHARSHINI HOSPITAL LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10531988.Hebbale Venkatesh Shubha is currently involved in 3 different roles. Their most recent position is with AUMKARA ONEHEALTH PRIVATE LIMITED as a Individual Subscriber. The first company Hebbale Venkatesh Shubha was appointed to as a director was NEW PRIYADHARSHINI HOSPITAL LLP. Hebbale Venkatesh Shubha is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (1)
Past Companies (0)
5 Months 3 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| PRANAVA LIFE SUPPORT SERVICES PRIVATE LIMITED | Director | 01-Mar-2025 |
| AUMKARA ONEHEALTH PRIVATE LIMITED | Individual Subscriber | 09-Dec-2025 |